Financials
- Market Capitalization 23.23 M
- Employee 40
- Founded 2015
- CEO N/A
- Website www.nextcure.com
- Headquarter Delaware, United States
- FIGI BBG00BTH5153
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.72
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4562 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.71 USD | +7.58% | +7.58% | +9.23% | -46.21% | 23.68 M USD | ||
| 4565 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.72 USD | -1.37% | +1.41% | -4.00% | -64.00% | 23.44 M USD | ||
| 4588 | CELU Celularity Inc. - Class A Common Stock | 0.78 USD | +2.63% | +6.85% | -2.50% | -67.77% | 22.58 M USD | ||
| 4595 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.62 USD | +0.22% | +5.01% | -6.46% | +132.82% | 22.05 M USD |